Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review

被引：0
|
作者：
Domenico Paolo Emanuele Margiotta
Fabio Basta
Veronica Batani
Antonella Afeltra
机构：
[1] Università Campus Bio-Medico di Roma,Unit of Allergology, Clinical Immunology and Rheumatology, Department of Medicine
来源：
BMC Nephrology | / 19卷
关键词：
Belimumab; Mycophenolate mofetil; Lupus nephritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review
    Margiotta, Domenico Paolo Emanuele
    Basta, Fabio
    Batani, Veronica
    Afeltra, Antonella
    BMC NEPHROLOGY, 2018, 19
  • [2] Mycophenolate mofetil therapy in resistant class IV lupus nephritis
    Grcevska, L
    Polenakovic, M
    Dzikova, S
    Milovanceva-Popovska, M
    ALLERGY, 2002, 57 : 168 - 168
  • [3] Belimumab and Multitarget Therapy, Mycophenolate Mofetil, and Tacrolimus as Induction Therapy of Severe Active Lupus Nephritis: Case Series From China
    Min, Min
    Zhang, Jiong
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 493 - 493
  • [4] Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus Cyclophosphamide
    Marwa Chbihi
    Laurye-Anne Eveillard
    Quentin Riller
    Romain Brousse
    Romain Berthaud
    Pierre Quartier
    Rémi Salomon
    Marina Charbit
    Marina Avramescu
    Nathalie Biebuyck
    Laurène Dehoux
    Nicolas Garcelon
    Jean-Paul Duong-Van-Huyen
    Brigitte Bader-Meunier
    Olivia Boyer
    Journal of Nephrology, 2023, 36 : 829 - 839
  • [5] Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus Cyclophosphamide
    Chbihi, Marwa
    Eveillard, Laurye-Anne
    Riller, Quentin
    Brousse, Romain
    Berthaud, Romain
    Quartier, Pierre
    Salomon, Remi
    Charbit, Marina
    Avramescu, Marina
    Biebuyck, Nathalie
    Dehoux, Laurene
    Garcelon, Nicolas
    Duong-Van-Huyen, Jean-Paul
    Bader-Meunier, Brigitte
    Boyer, Olivia
    JOURNAL OF NEPHROLOGY, 2023, 36 (03) : 829 - 839
  • [6] MYCOPHENOLATE MOFETIL INDUCTION THERAPY FOR CRESCENTIC LUPUS NEPHRITIS CLASS IV-G : A PROMISING OUTCOME
    Syeda, Ummerubab
    Daniel, Deepu
    Maarouf, Omar Hussein
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 71 (04) : 589 - 589
  • [7] Treatment of Class IV Lupus Nephritis with Mycophenolate Mofetil Monotherapy
    Nawata, Takashi
    Kubo, Makoto
    Fujii, Shohei
    Shiragami, Kosaku
    Ikegami, Tadayoshi
    Kobayashi, Shigeki
    Hisano, Satoshi
    Yano, Masafumi
    INTERNAL MEDICINE, 2018, 57 (14) : 2067 - 2070
  • [8] Mycophenolate mofetil in lupus nephritis and thrombocytopenia: A case series
    Penserga, E. G.
    Villarubin, A. O.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 477 - 477
  • [9] Efficacy and safety of cyclophosphamide combined with mycophenolate mofetil for induction treatment of class IV lupus nephritis
    Sun, Jian
    Zhang, Hao
    Ji, Ying
    Gui, Ming
    Yi, Bin
    Wang, Jianwen
    Jiang, Juan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (11): : 21572 - 21578
  • [10] Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
    Radhakrishnan, Jai
    Moutzouris, Dimitrios-Anestis
    Ginzler, Ellen M.
    Solomons, Neil
    Siempos, Ilias I.
    Appel, Gerald B.
    KIDNEY INTERNATIONAL, 2010, 77 (02) : 152 - 160
12345